Analyze Diet
Biomolecules2021; 11(8); doi: 10.3390/biom11081141

The Role of Mesenchymal Stem Cells (MSCs) in Veterinary Medicine and Their Use in Musculoskeletal Disorders.

Abstract: Regenerative medicine is a dynamically developing field of human and veterinary medicine. The animal model was most commonly used for mesenchymal stem cells (MSCs) treatment in experimental and preclinical studies with a satisfactory therapeutic effect. Year by year, the need for alternative treatments in veterinary medicine is increasing, and other applications for promising MSCs and their biological derivatives are constantly being sought. There is also an increase in demand for other methods of treating disease states, of which the classical treatment methods did not bring the desired results. Cell therapy can be a realistic option for treating human and animal diseases in the near future and therefore additional research is needed to optimize cell origins, numbers, or application methods in order to standardize the treatment process and assess its effects. The aim of the following work was to summarize available knowledge about stem cells in veterinary medicine and their possible application in the treatment of chosen musculoskeletal disorders in dogs and horses.
Publication Date: 2021-08-02 PubMed ID: 34439807PubMed Central: PMC8391453DOI: 10.3390/biom11081141Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on the growing role of mesenchymal stem cells (MSCs) in veterinary medicine, particularly in treating musculoskeletal disorders in animals such as dogs and horses. It discusses the increase in demand for alternative treatments where conventional ones fail and advocates for further research in stem cell therapy.

Understanding Regenerative Medicine and MSCs

  • The paper introduces regenerative medicine as a developing field in both human and veterinary medicine.
  • Mesenchymal stem cells (MSCs), used in regenerative medicine, are a major focus of the study. These cells have been widely used in preclinical and experimental studies using animal models.
  • The authors state that the studies have shown a satisfactory therapeutic effect, indicating that MSCs can be a viable alternative to traditional treatments.

Demand for Alternative Treatments

  • According to the authors, the demand for alternative treatments in veterinary medicine is on the rise.
  • This demand is driven by the lack of desired results from conventional treatment methods for various diseases.
  • The authors propose that cell therapy, such as the use of MSCs, could serve as a potential alternative treatment strategy.

Future of Cell Therapy

  • While advocating for the use of cell therapy, the authors also recognize the need for additional research in this field.
  • They stress the importance of optimizing crucial factors such as cell origins, numbers, and application methods to create a standardized treatment process.
  • By doing so, it will be easier to assess the effects of these treatments, further advancing the science of stem cell therapy.

Stem Cell Use in Veterinary Medicine

  • The paper summarises what is currently known about the use of stem cells in veterinary medicine, particularly with regard to treating musculoskeletal disorders in animals like dogs and horses.
  • This review of scientific literature contributes to a wider understanding of stem cell application in the veterinary medicine field.

Cite This Article

APA
Prządka P, Buczak K, Frejlich E, Gąsior L, Suliga K, Kiełbowicz Z. (2021). The Role of Mesenchymal Stem Cells (MSCs) in Veterinary Medicine and Their Use in Musculoskeletal Disorders. Biomolecules, 11(8). https://doi.org/10.3390/biom11081141

Publication

ISSN: 2218-273X
NlmUniqueID: 101596414
Country: Switzerland
Language: English
Volume: 11
Issue: 8

Researcher Affiliations

Prządka, Przemysław
  • Department of Surgery, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Science, Pl. Grunwadzki 51, 50-366 Wroclaw, Poland.
Buczak, Krzysztof
  • Department of Surgery, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Science, Pl. Grunwadzki 51, 50-366 Wroclaw, Poland.
Frejlich, Ewelina
  • 2nd Department of General Surgery and Surgical Oncology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.
Gąsior, Ludwika
  • Vets & Pets Veterinary Clinic, Zakladowa 11N, 50-231 Wroclaw, Poland.
Suliga, Kamil
  • Student Veterinary Surgical Society "LANCET", Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Science, Pl. Grunwaldzki 51, 50-366 Wroclaw, Poland.
Kiełbowicz, Zdzisław
  • Department of Surgery, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Science, Pl. Grunwadzki 51, 50-366 Wroclaw, Poland.

MeSH Terms

  • Adipose Tissue / cytology
  • Adipose Tissue / immunology
  • Animals
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / immunology
  • Cell- and Tissue-Based Therapy / methods
  • Cell- and Tissue-Based Therapy / veterinary
  • Dogs
  • Female
  • Horses
  • Humans
  • Mesenchymal Stem Cell Transplantation / methods
  • Mesenchymal Stem Cell Transplantation / veterinary
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / immunology
  • Musculoskeletal Diseases / immunology
  • Musculoskeletal Diseases / pathology
  • Musculoskeletal Diseases / therapy
  • Musculoskeletal Diseases / veterinary
  • Placenta / cytology
  • Placenta / immunology
  • Pregnancy
  • Regenerative Medicine / methods
  • Transplantation, Autologous
  • Transplantation, Homologous
  • Umbilical Cord / cytology
  • Umbilical Cord / immunology
  • Veterinary Medicine / methods

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 136 references
  1. Banas A. Stem Cells—Perspective and Dangers. Med. J. Rzesz. Univ. 2010;2:117–127.
  2. Krampera M, Franchini M, Pizzolo G, Aprili G. Mesenchymal Stem Cells: From Biology to Clinical Use. Blood Transfus. 2007;5:120.
    pmc: PMC2535891pubmed: 19204764
  3. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R.. Multilineage Potential of Adult Human Mesenchymal Stem Cells. Science 1999;284:143–147.
    doi: 10.1126/science.284.5411.143pubmed: 10102814google scholar: lookup
  4. Dziubińska P., Jaskólska M., Przyborowska P., Adamiak Z. Stem Cells in Dentistry–Review of Literature. Pol. J. Vet. Sci. 2013.
    doi: 10.2478/pjvs-2013-0021pubmed: 23691589google scholar: lookup
  5. Caplan A.I.. Mesenchymal Stem Cells. J. Orthop. Res. 1991;9:641–650.
    doi: 10.1002/jor.1100090504pubmed: 1870029google scholar: lookup
  6. Caplan A.I., Dennis J.E.. Mesenchymal Stem Cells as Trophic Mediators. J. Cell. Biochem. 2006;98:1076–1084.
    doi: 10.1002/jcb.20886pubmed: 16619257google scholar: lookup
  7. Ratajczak M., Zuba-Surma E., Ratajczak J.. Stem Cell Therapeutics—Hope and Concerns. Acta Haematol. Pol. 2009;40:289–303.
  8. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S.. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell 2007;131:861–872.
    doi: 10.1016/j.cell.2007.11.019pubmed: 18035408google scholar: lookup
  9. Yamanaka S.. Strategies and New Developments in the Generation of Patient-Specific Pluripotent Stem Cells. Cell Stem Cell 2007;1:39–49.
    doi: 10.1016/j.stem.2007.05.012pubmed: 18371333google scholar: lookup
  10. Yamanaka S.. Induced Pluripotent Stem Cells: Past, Present, and Future. Cell Stem Cell 2012;10:678–684.
    doi: 10.1016/j.stem.2012.05.005pubmed: 22704507google scholar: lookup
  11. Emadedin M., Aghdami N., Taghiyar L., Fazeli R., Moghadasali R., Jahangir S., Farjad R., Eslaminejad M.B.. Intra-Articular Injection of Autologous Mesenchymal Stem Cells in Six Patients with Knee Osteoarthritis. Arch. Iran. Med. 2012;15:422–428.
    pubmed: 22724879
  12. Frisbie D., Smith R.. Clinical Update on the Use of Mesenchymal Stem Cells in Equine Orthopaedics. Equine Vet. J. 2010;42:86–89.
    doi: 10.2746/042516409X477263pubmed: 20121921google scholar: lookup
  13. Guercio A., Di Marco P., Casella S., Cannella V., Russotto L., Purpari G., Di Bella S., Piccione G.. Production of Canine Mesenchymal Stem Cells from Adipose Tissue and Their Application in Dogs with Chronic Osteoarthritis of the Humeroradial Joints. Cell Biol. Int. 2012;36:189–194.
    doi: 10.1042/CBI20110304pubmed: 21936851google scholar: lookup
  14. Chopra H., Hans M.K., Shetty S.. Stem Cells—The Hidden Treasure: A Strategic Review. Dent. Res. J. 2013;10:421.
    pmc: PMC3793402pubmed: 24130574
  15. Emura M.. Stem Cells of the Respiratory Epithelium and Their in Vitro Cultivation. Vitr. Cell. Dev. Biol. Anim. 1997;33:3–14.
    doi: 10.1007/s11626-997-0015-4pubmed: 9028828google scholar: lookup
  16. Burdzinska A., Idziak M.. Stem Cells in Veterinary Medicine—Facts and Myths. Mag. Weter. 2013;7:695–704.
  17. Lin C.-S., Lin G., Lue T.F.. Allogeneic and Xenogeneic Transplantation of Adipose-Derived Stem Cells in Immunocompetent Recipients without Immunosuppressants. Stem Cells Dev. 2012;21:2770–2778.
    doi: 10.1089/scd.2012.0176pmc: PMC3806387pubmed: 22621212google scholar: lookup
  18. Kalisiak O., Cegielski M.. Stem Cells in Treatment of Tendon Disorders in Horses. Życie Weter. 2013;88:112–114.
  19. Cegielski M., Dziewiszek W., Zabel M., Dziegiel P., Kuryszko J., Izykowska I., Zatoński M., Bochnia M.. Experimental Xenoimplantation of Antlerogenic Cells into Mandibular Bone Lesions in Rabbits: Two-Year Follow-Up. Vivo 2010;24:165–172.
    pubmed: 20363989
  20. Cegielski M., Izykowska I., Chmielewska M., Dziewiszek W., Bochnia M., Calkosinski I., Dziegiel P.. Characteristics of MIC-1 Antlerogenic Stem Cells and Their Effect on Hair Growth in Rabbits. In Vivo 2013;27:97–106.
    pubmed: 23239857
  21. Cegielski M., Kalisiak O.. Stem Cells Therapy—A Hope For the Treatment of Tendons in Horses. Życie Weter. 2008;83:754–756.
  22. Takahashi K., Yamanaka S.. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell 2006;126:663–676.
    doi: 10.1016/j.cell.2006.07.024pubmed: 16904174google scholar: lookup
  23. Johansson C.B., Momma S., Clarke D.L., Risling M., Lendahl U., Frisén J.. Identification of a Neural Stem Cell in the Adult Mammalian Central Nervous System. Cell 1999;96:25–34.
    doi: 10.1016/S0092-8674(00)80956-3pubmed: 9989494google scholar: lookup
  24. Caplan A.. Why Are MSCs Therapeutic? New Data: New Insight. J. Pathol. A J. Pathol. Soc. Great Br. Irel. 2009;217:318–324.
    doi: 10.1002/path.2469pmc: PMC8793150pubmed: 19023885google scholar: lookup
  25. Jones E., McGonagle D.. Human Bone Marrow Mesenchymal Stem Cells in Vivo. Rheumatology 2008;47:126–131.
    doi: 10.1093/rheumatology/kem206pubmed: 17986482google scholar: lookup
  26. Jung D.-I., Ha J., Kang B.-T., Kim J.-W., Quan F.-S., Lee J.-H., Woo E.-J., Park H.-M.. A Comparison of Autologous and Allogenic Bone Marrow-Derived Mesenchymal Stem Cell Transplantation in Canine Spinal Cord Injury. J. Neurol. Sci. 2009;285:67–77.
    doi: 10.1016/j.jns.2009.05.027pubmed: 19555980google scholar: lookup
  27. Ding D.-C., Shyu W.-C., Lin S.-Z.. Mesenchymal Stem Cells. Cell Transplant. 2011;20:5–14.
    doi: 10.3727/096368910Xpubmed: 21396235google scholar: lookup
  28. Bearden R.N., Huggins S.S., Cummings K.J., Smith R., Gregory C.A., Saunders W.B.. In-Vitro Characterization of Canine Multipotent Stromal Cells Isolated from Synovium, Bone Marrow, and Adipose Tissue: A Donor-Matched Comparative Study. Stem Cell Res. Ther. 2017;8:1–22.
    doi: 10.1186/s13287-017-0639-6pmc: PMC5627404pubmed: 28974260google scholar: lookup
  29. Voga M., Adamic N., Vengust M., Majdic G.. Stem Cells in Veterinary Medicine—Current State and Treatment Options. Front. Vet. Sci. 2020;7:278.
    doi: 10.3389/fvets.2020.00278pmc: PMC7326035pubmed: 32656249google scholar: lookup
  30. Orbay H., Tobita M., Mizuno H.. Mesenchymal Stem Cells Isolated from Adipose and Other Tissues: Basic Biological Properties and Clinical Applications. Stem Cells Int. 2012;2012.
    doi: 10.1155/2012/461718pmc: PMC3361347pubmed: 22666271google scholar: lookup
  31. Godwin E., Young N., Dudhia J., Beamish I., Smith R.. Implantation of Bone Marrow-derived Mesenchymal Stem Cells Demonstrates Improved Outcome in Horses with Overstrain Injury of the Superficial Digital Flexor Tendon. Equine Vet. J. 2012;44:25–32.
  32. Jung D.-I., Ha J.-I., Kim J.-W., Kang B.-T., Yoo J.-H., Park C., Lee J.-H., Park H.-M.. Canine Mesenchymal Stem Cells Derived from Bone Marrow: Isolation, Characterization, Multidifferentiation, and Neurotrophic Factor Expression in Vitro. J. Vet. Clin. 2008;25:458–465.
  33. Peters A.E., Watts A.E.. Biopsy Needle Advancement during Bone Marrow Aspiration Increases Mesenchymal Stem Cell Concentration. Front. Vet. Sci. 2016;3:23.
    doi: 10.3389/fvets.2016.00023pmc: PMC4789557pubmed: 27014705google scholar: lookup
  34. Jacobs R., Kociba G., Ruoff W.. Monoclonal Gammopathy in a Horse with Defective Hemostasis. Vet. Pathol. 1983;20:643–647.
    doi: 10.1177/030098588302000520pubmed: 6636474google scholar: lookup
  35. Durando M., Zarucco L., Schaer T., Ross M., Reef V.. Pneumopericardium in a Horse Secondary to Sternal Bone Marrow Aspiration. Equine Vet. Educ. 2006;18:75–79.
  36. Désévaux C., Laverty S., Doizé B.. Sternal Bone Biopsy in Standing Horses. Vet. Surg. 2000;29:303–308.
    pubmed: 10917279
  37. Kasashima Y., Ueno T., Tomita A., Goodship A., Smith R.. Optimisation of Bone Marrow Aspiration from the Equine Sternum for the Safe Recovery of Mesenchymal Stem Cells. Equine Vet. J. 2011;43:288–294.
  38. Rebelatto C., Aguiar A., Moretao M., Senegaglia A., Hansen P., Barchiki F., Oliveira J., Martins J., Kuligovski C., Mansur F.. Dissimilar Differentiation of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, and Adipose Tissue. Exp. Biol. Med. 2008;233:901–913.
    doi: 10.3181/0712-RM-356pubmed: 18445775google scholar: lookup
  39. Webb T.L., Quimby J.M., Dow S.W.. In Vitro Comparison of Feline Bone Marrow-Derived and Adipose Tissue-Derived Mesenchymal Stem Cells. J. Feline Med. Surg. 2012;14:165–168.
    doi: 10.1177/1098612X11429224pmc: PMC10822480pubmed: 22314096google scholar: lookup
  40. Black L.L., Gaynor J., Gahring D., Adams C., Aron D., Harman S., Gingerich D.A., Harman R.. Effect of Adipose-Derived Mesenchymal Stem and Regenerative Cells on Lameness in Dogs with Chronic Osteoarthritis of the Coxofemoral Joints: A Randomized, Double-Blinded, Multicenter Controlled Trial. Vet. Ther. 2007;8:272.
    pubmed: 18183546
  41. Cuervo B., Rubio M., Sopena J., Dominguez J.M., Vilar J., Morales M., Cugat R., Carrillo J.M.. Hip Osteoarthritis in Dogs: A Randomized Study Using Mesenchymal Stem Cells from Adipose Tissue and Plasma Rich in Growth Factors. Int. J. Mol. Sci. 2014;15:13437–13460.
    doi: 10.3390/ijms150813437pmc: PMC4159804pubmed: 25089877google scholar: lookup
  42. Nicpon J., Marycz K., Grzesiak J.. Therapeutic Effect of Adipose-Derived Mesenchymal Stem Cell Injection in Horses Suffering from Bone Spavin. Pol. J. Vet. Sci. 2013;16:753–754.
    doi: 10.2478/pjvs-2013-0107pubmed: 24597313google scholar: lookup
  43. Vilar J.M., Morales M., Santana A., Spinella G., Rubio M., Cuervo B., Cugat R., Carrillo J.M.. Controlled, Blinded Force Platform Analysis of the Effect of Intraarticular Injection of Autologous Adipose-Derived Mesenchymal Stem Cells Associated to PRGF-Endoret in Osteoarthritic Dogs. BMC Vet. Res. 2013;9:131.
    doi: 10.1186/1746-6148-9-131pmc: PMC3716942pubmed: 23819757google scholar: lookup
  44. Kuznetsov S.A., Mankani M.H., Gronthos S., Satomura K., Bianco P., Robey P.G.. Circulating Skeletal Stem Cells. J. Cell Biol. 2001;153:1133–1140.
    doi: 10.1083/jcb.153.5.1133pmc: PMC2174322pubmed: 11381097google scholar: lookup
  45. Koerner J., Nesic D., Romero J.D., Brehm W., Grogan S.P.. Equine Peripheral Blood-Derived Progenitors in Comparison to Bone Marrow-Derived Mesenchymal Stem Cells. Stem Cells 2006;24:1613–1619.
    doi: 10.1634/stemcells.2005-0264pubmed: 16769763google scholar: lookup
  46. Dhar M., Neilsen N., Beatty K., Eaker S., Adair H., Geiser D.. Equine Peripheral Blood-Derived Mesenchymal Stem Cells: Isolation, Identification, Trilineage Differentiation and Effect of Hyperbaric Oxygen Treatment. Equine Vet. J. 2012;44:600–605.
  47. Spaas J.H., De Schauwer C., Cornillie P., Meyer E., Van Soom A., Van de Walle G.R.. Culture and Characterisation of Equine Peripheral Blood Mesenchymal Stromal Cells. Vet. J. 2013;195:107–113.
    doi: 10.1016/j.tvjl.2012.05.006pubmed: 22717781google scholar: lookup
  48. Bieback K., Kern S., Klüter H., Eichler H.. Critical Parameters for the Isolation of Mesenchymal Stem Cells from Umbilical Cord Blood. Stem Cells 2004;22:625–634.
    doi: 10.1634/stemcells.22-4-625pubmed: 15277708google scholar: lookup
  49. In’t Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., de Groot-Swings G.M., Claas F.H., Fibbe W.E., Kanhai H.H.. Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta. Stem Cells 2004;22:1338–1345.
    doi: 10.1634/stemcells.2004-0058pubmed: 15579651google scholar: lookup
  50. In’t Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., Noort W.A., Claas F.H.J., Willemze R., Fibbe W.E., Kanhai H.H.H.. Amniotic Fluid as a Novel Source of Mesenchymal Stem Cells for Therapeutic Transplantation. Blood 2003;102:1548–1549.
    doi: 10.1182/blood-2003-04-1291pubmed: 12900350google scholar: lookup
  51. Chen M.-Y., Lie P.-C., Li Z.-L., Wei X.. Endothelial Differentiation of Wharton’s Jelly–Derived Mesenchymal Stem Cells in Comparison with Bone Marrow–Derived Mesenchymal Stem Cells. Exp. Hematol. 2009;37:629–640.
    doi: 10.1016/j.exphem.2009.02.003pubmed: 19375653google scholar: lookup
  52. Li X., Zhou S.G., Imreh M.P., Ährlund-Richter L., Allen W.R.. Horse Embryonic Stem Cell Lines from the Proliferation of Inner Cell Mass Cells. Stem Cells Dev. 2006;15:523–531.
    doi: 10.1089/scd.2006.15.523pubmed: 16978056google scholar: lookup
  53. Hoynowski S.M., Fry M.M., Gardner B.M., Leming M.T., Tucker J.R., Black L., Sand T., Mitchell K.E.. Characterization and Differentiation of Equine Umbilical Cord-Derived Matrix Cells. Biochem. Biophys. Res. Commun. 2007;362:347–353.
    doi: 10.1016/j.bbrc.2007.07.182pubmed: 17719011google scholar: lookup
  54. Passeri S., Nocchi F., Lamanna R., Lapi S., Miragliotta V., Giannessi E., Abramo F., Stornelli M.R., Matarazzo M., Plenteda D.. Isolation and Expansion of Equine Umbilical Cord-Derived Matrix Cells (EUCMCs). Cell Biol. Int. 2009;33:100–105.
    doi: 10.1016/j.cellbi.2008.10.012pubmed: 18996215google scholar: lookup
  55. Prządka P., Kiełbowicz Z., Osiński B., Dzimira S., Madej J.A., Nowacki W., Kubiak K., Reichert P., Cegielski M.. Reconstruction of Cranial Cruciate Ligament in Rabbits Using Polyester Implants Saturated with PRP, Antlerogenic Stem Cells MIC-1 and Their Homogenate. Connect. Tissue Res. 2017;58:464–478.
    doi: 10.1080/03008207.2016.1251911pubmed: 27791406google scholar: lookup
  56. Penha E.M., Meira C.S., Guimarães E.T., Mendonça M.V.P., Gravely F.A., Pinheiro C.M.B., Pinheiro T.M.B., Barrouin-Melo S.M., Ribeiro-dos-Santos R., Soares M.B.P.. Use of Autologous Mesenchymal Stem Cells Derived from Bone Marrow for the Treatment of Naturally Injured Spinal Cord in Dogs. Stem Cells Int. 2014;2014.
    doi: 10.1155/2014/437521pmc: PMC3956412pubmed: 24723956google scholar: lookup
  57. Feng M., Lu A., Gao H., Qian C., Zhang J., Lin T., Zhao Y.. Safety of Allogeneic Umbilical Cord Blood Stem Cells Therapy in Patients with Severe Cerebral Palsy: A Retrospective Study. Stem Cells Int. 2015;2015.
    doi: 10.1155/2015/325652pmc: PMC4510256pubmed: 26236347google scholar: lookup
  58. Lee S.Y., Kim W., Lim C., Chung S.G.. Treatment of Lateral Epicondylosis by Using Allogeneic Adipose-Derived Mesenchymal Stem Cells: A Pilot Study. Stem Cells 2015;33:2995–3005.
    doi: 10.1002/stem.2110pubmed: 26202898google scholar: lookup
  59. Sullivan M.J.. Banking on Cord Blood Stem Cells. Nat. Rev. Cancer 2008;8:555–563.
    doi: 10.1038/nrc2418pubmed: 18548085google scholar: lookup
  60. Bertoni L., Branly T., Jacquet S., Desance M., Desquilbet L., Pascaline R., Hartmann D.-J., Denoix J.-M., Audigie F., Galera P.. Intra-Articular Injection of 2 Different Dosages of Autologous and Allogeneic Bone Marrow- and Umbilical Cord-Derived Mesenchymal Stem Cells Triggers a Variable Inflammatory Response of the Fetlock Joint on 12 Sound Experimental Horses. Stem Cells Int. 2019.
    doi: 10.1155/2019/9431894pmc: PMC6525957pubmed: 31191689google scholar: lookup
  61. Devine S.M., Bartholomew A.M., Mahmud N., Nelson M., Patil S., Hardy W., Sturgeon C., Hewett T., Chung T., Stock W.. Mesenchymal Stem Cells Are Capable of Homing to the Bone Marrow of Non-Human Primates Following Systemic Infusion. Exp. Hematol. 2001;29:244–255.
    doi: 10.1016/S0301-472X(00)00635-4pubmed: 11166464google scholar: lookup
  62. Saito T., Kuang J.-Q., Bittira B., Al-Khaldi A., Chiu R.C.-J.. Xenotransplant Cardiac Chimera: Immune Tolerance of Adult Stem Cells. Ann. Thorac. Surg. 2002;74:19–24.
    doi: 10.1016/S0003-4975(02)03591-9pubmed: 12118756google scholar: lookup
  63. Kim H.-J., Park J.-B., Lee J.K., Park E.-Y., Park E.-A., Riew K.D., Rhee S.-K.. Transplanted Xenogenic Bone Marrow Stem Cells Survive and Generate New Bone Formation in the Posterolateral Lumbar Spine of Non-Immunosuppressed Rabbits. Eur. Spine J. 2008;17:1515–1521.
    doi: 10.1007/s00586-008-0784-9pmc: PMC2583184pubmed: 18815818google scholar: lookup
  64. Pal R., Gopinath C., Rao N.M., Banerjee P., Krishnamoorthy V., Venkataramana N.K., Totey S.. Functional Recovery after Transplantation of Bone Marrow-Derived Human Mesenchymal Stromal Cells in a Rat Model of Spinal Cord Injury. Cytotherapy 2010;12:792–806.
    doi: 10.3109/14653249.2010.487899pubmed: 20524772google scholar: lookup
  65. Guan M., Yao W., Liu R., Lam K.S., Nolta J., Jia J., Panganiban B., Meng L., Zhou P., Shahnazari M.. Directing Mesenchymal Stem Cells to Bone to Augment Bone Formation and Increase Bone Mass. Nat. Med. 2012;18:456–462.
    doi: 10.1038/nm.2665pmc: PMC3755884pubmed: 22306732google scholar: lookup
  66. Sharma P., Kumar P., Sharma R.. The Major Histocompatibility Complex: A Review. Asian J. Pharm. Clin. Res. 2017;10:33–36.
  67. Wieczorek M., Abualrous E.T., Sticht J., Álvaro-Benito M., Stolzenberg S., Noé F., Freund C.. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation. Front. Immunol. 2017;8:292.
    doi: 10.3389/fimmu.2017.00292pmc: PMC5355494pubmed: 28367149google scholar: lookup
  68. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R.. Mesenchymal Stem Cells Suppress Lymphocyte Proliferation in Vitro and Prolong Skin Graft Survival in Vivo. Exp. Hematol. 2002;30:42–48.
    doi: 10.1016/S0301-472X(01)00769-Xpubmed: 11823036google scholar: lookup
  69. Corcione A., Benvenuto F., Ferretti E., Giunti D., Cappiello V., Cazzanti F., Risso M., Gualandi F., Mancardi G.L., Pistoia V.. Human Mesenchymal Stem Cells Modulate B-Cell Functions. Blood 2006;107:367–372.
    doi: 10.1182/blood-2005-07-2657pubmed: 16141348google scholar: lookup
  70. Javazon E.H., Beggs K.J., Flake A.W.. Mesenchymal Stem Cells: Paradoxes of Passaging. Exp. Hematol. 2004;32:414–425.
    doi: 10.1016/j.exphem.2004.02.004pubmed: 15145209google scholar: lookup
  71. Opiela J., Samiec M.. Characterization of Mesenchymal Stem Cells and Their Application in Experimental Embryology. Pol. J. Vet. Sci. 2013;16:593–599.
    doi: 10.2478/pjvs-2013-0084pubmed: 24195301google scholar: lookup
  72. de Vasconcellos Machado C., da Silva Telles P.D., Nascimento I.L.O.. Immunological Characteristics of Mesenchymal Stem Cells. Rev. Bras. Hematol. Hemoter. 2013;35:62–67.
    doi: 10.5581/1516-8484.20130017pmc: PMC3621638pubmed: 23580887google scholar: lookup
  73. Guest D., Smith M., Allen W.. Monitoring the Fate of Autologous and Allogeneic Mesenchymal Progenitor Cells Injected into the Superficial Digital Flexor Tendon of Horses: Preliminary Study. Equine Vet. J. 2008;40:178–181.
    doi: 10.2746/042516408X276942pubmed: 18267891google scholar: lookup
  74. Fortier L.A.. Stem Cells: Classifications, Controversies, and Clinical Applications. Vet. Surg. 2005;34:415–423.
  75. Barussi F.C., Bastos F.Z., Leite L.M., Fragoso F.Y., Senegaglia A.C., Brofman P.R., Nishiyama A., Pimpão C.T., Michelotto Jr P.V.. Intratracheal Therapy with Autologous Bone Marrow-Derived Mononuclear Cells Reduces Airway Inflammation in Horses with Recurrent Airway Obstruction. Respir. Physiol. Neurobiol. 2016;232:35–42.
    doi: 10.1016/j.resp.2016.07.002pubmed: 27396936google scholar: lookup
  76. Quimby J.M., Webb T.L., Habenicht L.M., Dow S.W.. Safety and Efficacy of Intravenous Infusion of Allogeneic Cryopreserved Mesenchymal Stem Cells for Treatment of Chronic Kidney Disease in Cats: Results of Three Sequential Pilot Studies. Stem Cell Res. Ther. 2013;4:1–12.
    doi: 10.1186/scrt198pmc: PMC3707049pubmed: 23632128google scholar: lookup
  77. Quimby J.M., Webb T.L., Gibbons D.S., Dow S.W.. Evaluation of Intrarenal Mesenchymal Stem Cell Injection for Treatment of Chronic Kidney Disease in Cats: A Pilot Study. J. Feline Med. Surg. 2011;13:418–426.
    doi: 10.1016/j.jfms.2011.01.005pmc: PMC10832716pubmed: 21334237google scholar: lookup
  78. Kim S.-J., Park K.C., Lee J.U., Kim K.-J., Kim D.-G.. Therapeutic Potential of Adipose Tissue-Derived Stem Cells for Liver Failure According to the Transplantation Routes. J. Korean Surg. Soc. 2011;81:176–186.
    doi: 10.4174/jkss.2011.81.3.176pmc: PMC3204543pubmed: 22066119google scholar: lookup
  79. Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., Osaki M., Kawamata M., Kato T., Okochi H., Ochiya T.. IFATS Collection: In Vivo Therapeutic Potential of Human Adipose Tissue Mesenchymal Stem Cells after Transplantation into Mice with Liver Injury. Stem Cells 2008;26:2705–2712.
    doi: 10.1634/stemcells.2008-0034pubmed: 18535155google scholar: lookup
  80. Duncan A.W., Dorrell C., Grompe M.. Stem Cells and Liver Regeneration. Gastroenterology 2009;137:466–481.
  81. Pascual-Miguelañez I., Salinas-Gomez J., Fernandez-Luengas D., Villar-Zarra K., Clemente L.V., Garcia-Arranz M., Olmo D.G.. Systemic Treatment of Acute Liver Failure with Adipose Derived Stem Cells. J. Investig. Surg. 2015;28:120–126.
    doi: 10.3109/08941939.2014.987407pubmed: 25517764google scholar: lookup
  82. Yan Y., Fang J., Wen X., Teng X., Li B., Zhou Z., Peng S., Arisha A.H., Liu W., Hua J.. Therapeutic Applications of Adipose-Derived Mesenchymal Stem Cells on Acute Liver Injury in Canines. Res. Vet. Sci. 2019;126:233–239.
    doi: 10.1016/j.rvsc.2019.09.004pubmed: 31635840google scholar: lookup
  83. Ryu H.-H., Kang B.-J., Park S.-S., Kim Y., Sung G.-J., Woo H.-M., Kim W.H., Kweon O.-K.. Comparison of Mesenchymal Stem Cells Derived from Fat, Bone Marrow, Wharton’s Jelly, and Umbilical Cord Blood for Treating Spinal Cord Injuries in Dogs. J. Vet. Med. Sci. 2012.
    doi: 10.1292/jvms.12-0065pubmed: 22878503google scholar: lookup
  84. Strasser H., Berjukow S., Marksteiner R., Margreiter E., Hering S., Bartsch G., Hering S.. Stem Cell Therapy for Urinary Stress Incontinence. J. Urol. 2006;175:1801.
    doi: 10.1016/S0022-5347(06)00208-4pubmed: 15489048google scholar: lookup
  85. El-Menoufy H., Aly L., Aziz M., Atta H., Roshdy N., Rashed L., Sabry D.. The Role of Bone Marrow-derived Mesenchymal Stem Cells in Treating Formocresol Induced Oral Ulcers in Dogs. J. Oral Pathol. Med. 2010;39:281–289.
  86. Nitahara-Kasahara Y., Hayashita-Kinoh H., Ohshima-Hosoyama S., Okada H., Wada-Maeda M., Nakamura A., Okada T., Takeda S.. Long-Term Engraftment of Multipotent Mesenchymal Stromal Cells That Differentiate to Form Myogenic Cells in Dogs with Duchenne Muscular Dystrophy. Mol. Ther. 2012;20:168–177.
    doi: 10.1038/mt.2011.181pmc: PMC3255589pubmed: 21934652google scholar: lookup
  87. Bigham-Sadegh A., Mirshokraei P., Karimi I., Oryan A., Aparviz A., Shafiei-Sarvestani Z.. Effects of Adipose Tissue Stem Cell Concurrent with Greater Omentum on Experimental Long-Bone Healing in Dog. Connect. Tissue Res. 2012;53:334–342.
    doi: 10.3109/03008207.2012.660585pubmed: 22268489google scholar: lookup
  88. Min B.-H., Woo J.-I., Kim W.H., Kweon O.-K., Triffitt J.T., Choi B.H., Park S.R.. The Fate of Implanted Autologous Chondrocytes in Regenerated Articular Cartilage. Proc. Inst. Mech. Eng. Part. H J. Eng. Med. 2007;221:461–465.
    doi: 10.1243/09544119JEIM202pubmed: 17822148google scholar: lookup
  89. Zhu S., Lu Y., Zhu J., Xu J., Huang H., Zhu M., Chen Y., Zhou Y., Fan X., Wang Z.. Effects of Intrahepatic Bone-Derived Mesenchymal Stem Cells Autotransplantation on the Diabetic Beagle Dogs. J. Surg. Res. 2011;168:213–223.
    doi: 10.1016/j.jss.2009.10.008pubmed: 20097376google scholar: lookup
  90. Kirkby Shaw K., Alvarez L., Foster S.A., Tomlinson J.E., Shaw A.J., Pozzi A.. Fundamental Principles of Rehabilitation and Musculoskeletal Tissue Healing. Vet. Surg. 2020;49:22–32.
    doi: 10.1111/vsu.13270pmc: PMC6973127pubmed: 31271225google scholar: lookup
  91. Anderson A.. Treatment of Hip Dysplasia. J. Small Anim. Pract. 2011;52:182–189.
  92. Lascelles B.D.X., Brown D.C., Conzemius M.G., Gill M., Oshinsky M.L., Sharkey M.. Measurement of Chronic Pain in Companion Animals: Discussions from the Pain in Animals Workshop (PAW) 2017. Vet. J. 2019;250:71–78.
    doi: 10.1016/j.tvjl.2019.07.001pubmed: 31383423google scholar: lookup
  93. Magri C., Schramme M., Febre M., Cauvin E., Labadie F., Saulnier N., François I., Lechartier A., Aebischer D., Moncelet A.-S.. Comparison of Efficacy and Safety of Single versus Repeated Intra-Articular Injection of Allogeneic Neonatal Mesenchymal Stem Cells for Treatment of Osteoarthritis of the Metacarpophalangeal/Metatarsophalangeal Joint in Horses: A Clinical Pilot Study. PLoS ONE 2019;14.
  94. Kim S.E., Pozzi A., Yeh J., Lopez-Velazquez M., Au Yong J.A., Townsend S., Dunlap A.E., Christopher S.A., Lewis D.D., Johnson M.D.. Intra-Articular Umbilical Cord Derived Mesenchymal Stem Cell Therapy for Chronic Elbow Osteoarthritis in Dogs: A Double-Blinded, Placebo-Controlled Clinical Trial. Front. Vet. Sci. 2019;6:474.
    doi: 10.3389/fvets.2019.00474pmc: PMC6932969pubmed: 31921927google scholar: lookup
  95. Black L.L., Gaynor J., Adams C., Dhupa S., Sams A.E., Taylor R., Harman S., Gingerich D.A., Harman R.. Effect of Intraarticular Injection of Autologous Adipose-Derived Mesenchymal Stem and Regenerative Cells on Clinical Signs of Chronic Osteoarthritis of the Elbow Joint in Dogs. Vet. Ther. Res. Appl. Vet. Med. 2008;9:192–200.
    pubmed: 19003780
  96. Broeckx S.Y., Seys B., Suls M., Vandenberghe A., Mariën T., Adriaensen E., Declercq J., Van Hecke L., Braun G., Hellmann K.. Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses. Stem Cells 2019;28:410–422.
    doi: 10.1089/scd.2018.0061pmc: PMC6441287pubmed: 30623737google scholar: lookup
  97. Marx C., Silveira M.D., Selbach I., da Silva A.S., Gomes de Macedo Braga L.M., Camassola M., Nardi N.B.. Acupoint Injection of Autologous Stromal Vascular Fraction and Allogeneic Adipose-Derived Stem Cells to Treat Hip Dysplasia in Dogs. Stem Cells Int. 2014;2014.
    doi: 10.1155/2014/391274pmc: PMC4144304pubmed: 25180040google scholar: lookup
  98. McIlwraith C.W., Frisbie D.D., Rodkey W.G., Kisiday J.D., Werpy N.M., Kawcak C.E., Steadman J.R.. Evaluation of Intra-Articular Mesenchymal Stem Cells to Augment Healing of Microfractured Chondral Defects. Arthrosc. J. Arthrosc. Relat. Surg. 2011;27:1552–1561.
    doi: 10.1016/j.arthro.2011.06.002pubmed: 21862278google scholar: lookup
  99. Zhang B., Wang B., Li S., Luo D., Zhan X., Chen S., Chen Z., Liu C., Ji H., Bai Y.. Evaluation of the Curative Effect of Umbilical Cord Mesenchymal Stem Cell Therapy for Knee Arthritis in Dogs Using Imaging Technology. Stem Cells Int. 2018;2018.
    doi: 10.1155/2018/1983025pmc: PMC5976915pubmed: 29861739google scholar: lookup
  100. Yun S., Ku S.-K., Kwon Y.-S.. Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma Synergistically Ameliorate the Surgical-Induced Osteoarthritis in Beagle Dogs. J. Orthop. Surg. Res. 2016;11:1–12.
    doi: 10.1186/s13018-016-0342-9pmc: PMC4714505pubmed: 26768536google scholar: lookup
  101. Kemilew J., Sobczyńska-Rak A., Żylińska B., Szponder T., Nowicka B., Urban B.. The Use of Allogenic Stromal Vascular Fraction (SVF) Cells in Degenerative Joint Disease of the Spine in Dogs. In Vivo 2019;33:1109–1117.
    doi: 10.21873/invivo.11580pmc: PMC6689365pubmed: 31280199google scholar: lookup
  102. Broeckx S., Suls M., Beerts C., Vandenberghe A., Seys B., Wuertz-Kozak K., Duchateau L., H Spaas J.. Allogenic Mesenchymal Stem Cells as a Treatment for Equine Degenerative Joint Disease: A Pilot Study. Curr. Stem Cell Res. Ther. 2014;9:497–503.
  103. Beerts C., Suls M., Broeckx S.Y., Seys B., Vandenberghe A., Declercq J., Duchateau L., Vidal M.A., Spaas J.H.. Tenogenically Induced Allogeneic Peripheral Blood Mesenchymal Stem Cells in Allogeneic Platelet-Rich Plasma: 2-Year Follow-up after Tendon or Ligament Treatment in Horses. Front. Vet. Sci. 2017;4:158.
    doi: 10.3389/fvets.2017.00158pmc: PMC5622984pubmed: 29018808google scholar: lookup
  104. Canapp Jr S.O., Leasure C.S., Cox C., Ibrahim V., Carr B.J.. Partial Cranial Cruciate Ligament Tears Treated with Stem Cell and Platelet-Rich Plasma Combination Therapy in 36 Dogs: A Retrospective Study. Front. Vet. Sci. 2016;3:112.
    doi: 10.3389/fvets.2016.00112pmc: PMC5155010pubmed: 28018908google scholar: lookup
  105. Romero A., Barrachina L., Ranera B., Remacha A., Moreno B., De Blas I., Sanz A., Vázquez F., Vitoria A., Junquera C.. Comparison of Autologous Bone Marrow and Adipose Tissue Derived Mesenchymal Stem Cells, and Platelet Rich Plasma, for Treating Surgically Induced Lesions of the Equine Superficial Digital Flexor Tendon. Vet. J. 2017;224:76–84.
    doi: 10.1016/j.tvjl.2017.04.005pubmed: 28697880google scholar: lookup
  106. McDougall R.A., Canapp S.O., Canapp D.A.. Ultrasonographic Findings in 41 Dogs Treated with Bone Marrow Aspirate Concentrate and Platelet-Rich Plasma for a Supraspinatus Tendinopathy: A Retrospective Study. Front. Vet. Sci. 2018;5:98.
    doi: 10.3389/fvets.2018.00098pmc: PMC5967230pubmed: 29868619google scholar: lookup
  107. Canapp S.O., Jr., Canapp D.A., Ibrahim V., Carr B.J., Cox C., Barrett J.G.. The Use of Adipose-Derived Progenitor Cells and Platelet-Rich Plasma Combination for the Treatment of Supraspinatus Tendinopathy in 55 Dogs: A Retrospective Study. Front. Vet. Sci. 2016;3:61.
    doi: 10.3389/fvets.2016.00061pmc: PMC5016533pubmed: 27668218google scholar: lookup
  108. Carvalho A.M., Badial P.R., Álvarez L.E.C., Yamada A.L.M., Borges A.S., Deffune E., Hussni C.A., Alves A.L.G.. Equine Tendonitis Therapy Using Mesenchymal Stem Cells and Platelet Concentrates: A Randomized Controlled Trial. Stem Cell Res. Ther. 2013;4:1–13.
    doi: 10.1186/scrt236pmc: PMC3854756pubmed: 23876512google scholar: lookup
  109. Pacini S., Spinabella S., Trombi L., Fazzi R., Galimberti S., Dini F., Carlucci F., Petrini M.. Suspension of Bone Marrow–Derived Undifferentiated Mesenchymal Stromal Cells for Repair of Superficial Digital Flexor Tendon in Race Horses. Tissue Eng. 2007;13:2949–2955.
    doi: 10.1089/ten.2007.0108pubmed: 17919069google scholar: lookup
  110. Malek S., Sample S.J., Schwartz Z., Nemke B., Jacobson P.B., Cozzi E.M., Schaefer S.L., Bleedorn J.A., Holzman G., Muir P.. Effect of Analgesic Therapy on Clinical Outcome Measures in a Randomized Controlled Trial Using Client-Owned Dogs with Hip Osteoarthritis. BMC Vet. Res. 2012;8:1–17.
    doi: 10.1186/1746-6148-8-185pmc: PMC3527270pubmed: 23035739google scholar: lookup
  111. Rychel J.K.. Diagnosis and Treatment of Osteoarthritis. Top. Companion Anim. Med. 2010;25:20–25.
    doi: 10.1053/j.tcam.2009.10.005pubmed: 20188335google scholar: lookup
  112. Jüni P., Reichenbach S., Dieppe P.. Osteoarthritis: Rational Approach to Treating the Individual. Best Pract. Res. Clin. Rheumatol. 2006;20:721–740.
    doi: 10.1016/j.berh.2006.05.002pubmed: 16979535google scholar: lookup
  113. Kuyinu E.L., Narayanan G., Nair L.S., Laurencin C.T.. Animal Models of Osteoarthritis: Classification, Update, and Measurement of Outcomes. J. Orthop. Surg. Res. 2016;11:1–27.
    doi: 10.1186/s13018-016-0346-5pmc: PMC4738796pubmed: 26837951google scholar: lookup
  114. Sasaki A., Mizuno M., Mochizuki M., Sekiya I.. Mesenchymal Stem Cells for Cartilage Regeneration in Dogs. World J. Stem Cells. 2019;11:254.
    doi: 10.4252/wjsc.v11.i5.254pmc: PMC6545524pubmed: 31171954google scholar: lookup
  115. Clegg P., Booth T.. Drugs Used to Treat Osteoarthritis in the Horse. In Pract. 2000;22:594–603.
    doi: 10.1136/inpract.22.10.594google scholar: lookup
  116. Li F., Jia H., Yu C.. ACL Reconstruction in a Rabbit Model Using Irradiated Achilles Allograft Seeded with Mesenchymal Stem Cells or PDGF-B Gene-Transfected Mesenchymal Stem Cells. Knee Surg. Sports Traumatol. Arthrosc. 2007;15:1219–1227.
    doi: 10.1007/s00167-007-0385-xpubmed: 17687543google scholar: lookup
  117. Sharma P., Maffulli N.. Tendon Injury and Tendinopathy: Healing and Repair. J. Bone Jt. Surg. 2005;87:187–202.
    pubmed: 15634833
  118. Ortved K.F.. Regenerative Medicine and Rehabilitation for Tendinous and Ligamentous Injuries in Sport Horses. Vet. Clin. Equine Pract. 2018;34:359–373.
    doi: 10.1016/j.cveq.2018.04.012pubmed: 29803299google scholar: lookup
  119. Lipman K., Wang C., Ting K., Soo C., Zheng Z.. Tendinopathy: Injury, Repair, and Current Exploration. Drug Des. Dev. Ther. 2018;12:591.
    doi: 10.2147/DDDT.S154660pmc: PMC5865563pubmed: 29593382google scholar: lookup
  120. Snow L.A., White R., Gustafson S., Xie L., Hosgood G., Monroe W.T., Casey J.P., Lopez M.J.. Ex Vivo Comparison of Three Surgical Techniques to Stabilize Canine Cranial Cruciate Ligament Deficient Stifles. Vet. Surg. 2010;39:195–207.
  121. Hsu S.-L., Liang R., Woo S.L.. Functional Tissue Engineering of Ligament Healing. BMC Sports Sci. Med. Rehabil. 2010;2:1–10.
    doi: 10.1186/1758-2555-2-12pmc: PMC2879239pubmed: 20492676google scholar: lookup
  122. Lu H.H., Cooper J.A., Jr., Manuel S., Freeman J.W., Attawia M.A., Ko F.K., Laurencin C.T.. Anterior Cruciate Ligament Regeneration Using Braided Biodegradable Scaffolds: In Vitro Optimization Studies. Biomaterials 2005;26:4805–4816.
  123. Witte S., Dedman C., Harriss F., Kelly G., Chang Y.-M., Witte T.. Comparison of Treatment Outcomes for Superficial Digital Flexor Tendonitis in National Hunt Racehorses. Vet. J. 2016;216:157–163.
    doi: 10.1016/j.tvjl.2016.08.003pubmed: 27687944google scholar: lookup
  124. Canapp S.O., Canapp D.A., Carr B.J., Cox C., Barrett J.G.. Supraspinatus Tendinopathy in 327 Dogs: A Retrospective Study. Vet. Evid. 2016;1.
    doi: 10.18849/ve.v1i3.32pmc: PMC5016533pubmed: 27668218google scholar: lookup
  125. Becker W., Kowaleski M.P., McCarthy R.J., Blake C.A.. Extracorporeal Shockwave Therapy for Shoulder Lameness in Dogs. J. Am. Anim. Hosp. Assoc. 2015;51:15–19.
    doi: 10.5326/JAAHA-MS-6175pubmed: 25415219google scholar: lookup
  126. Mora M.V., Ibán M.A.R., Heredia J.D., Laakso R.B., Cuéllar R., Arranz M.G.. Stem Cell Therapy in the Management of Shoulder Rotator Cuff Disorders. World J. Stem Cells. 2015;7:691.
    doi: 10.4252/wjsc.v7.i4.691pmc: PMC4444610pubmed: 26029341google scholar: lookup
  127. Herthel D.J.. Enhanced Suspensory Ligament Healing in 100 Horses by Stem Cells and Other Bone Marrow Components. Am. Assoc. Equine Pract. 2001;47:319–321.
  128. Smith R., Korda M., Blunn G., Goodship A.. Isolation and Implantation of Autologous Equine Mesenchymal Stem Cells from Bone Marrow into the Superficial Digital Flexor Tendon as a Potential Novel Treatment. Equine Vet. J. 2003;35:99–102.
    doi: 10.2746/042516403775467388pubmed: 12553472google scholar: lookup
  129. Richardson L.E., Dudhia J., Clegg P.D., Smith R.. Stem Cells in Veterinary Medicine–Attempts at Regenerating Equine Tendon after Injury. Trends Biotechnol. 2007;25:409–416.
    doi: 10.1016/j.tibtech.2007.07.009pubmed: 17692415google scholar: lookup
  130. Nixon A.J., Dahlgren L.A., Haupt J.L., Yeager A.E., Ward D.L.. Effect of Adipose-Derived Nucleated Cell Fractions on Tendon Repair in Horses with Collagenase-Induced Tendinitis. Am. J. Vet. Res. 2008;69:928–937.
    doi: 10.2460/ajvr.69.7.928pubmed: 18593247google scholar: lookup
  131. Smith R.K.W., Werling N.J., Dakin S.G., Alam R., Goodship A.E., Dudhia J.. Beneficial Effects of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Naturally Occurring Tendinopathy. PLoS ONE 2013;8.
  132. Smith R., Webbon P.. Harnessing the Stem Cell for the Treatment of Tendon Injuries: Heralding a New Dawn?. Br. J. Sports Med. 2005;39:582–584.
    doi: 10.1136/bjsm.2005.015834pmc: PMC1725307pubmed: 16118291google scholar: lookup
  133. Smith R.K.. Mesenchymal Stem Cell Therapy for Equine Tendinopathy. Disabil. Rehabil. 2008;30:1752–1758.
    doi: 10.1080/09638280701788241pubmed: 18608378google scholar: lookup
  134. Khan W.S., Johnson D.S., Hardingham T.E.. The Potential of Stem Cells in the Treatment of Knee Cartilage Defects. Knee 2010;17:369–374.
    doi: 10.1016/j.knee.2009.12.003pubmed: 20051319google scholar: lookup
  135. Bianchi F., Maioli M., Leonardi E., Olivi E., Pasquinelli G., Valente S., Mendez A.J., Ricordi C., Raffaini M., Tremolada C.. A New Nonenzymatic Method and Device to Obtain a Fat Tissue Derivative Highly Enriched in Pericyte-like Elements by Mild Mechanical Forces from Human Lipoaspirates. Cell Transplant. 2013;22:2063–2077.
    doi: 10.3727/096368912X657855pubmed: 23051701google scholar: lookup
  136. Zomorodian E., Baghaban Eslaminejad M.. Mesenchymal Stem Cells as a Potent Cell Source for Bone Regeneration. Stem Cells Int. 2012;2012.
    doi: 10.1155/2012/980353pmc: PMC3289837pubmed: 22448175google scholar: lookup

Citations

This article has been cited 20 times.
  1. Sabzpoosh M, Hoveizi E, Gooraninejad S. Isolation and differentiation of endometrial mesenchymal stem cells from Arabian mares. In Vitro Cell Dev Biol Anim 2025 Dec;61(10):1187-1192.
    doi: 10.1007/s11626-025-01103-5pubmed: 41288937google scholar: lookup
  2. Banu SA, Mamachan M, El-Husseiny HM, Golchin A, Sharun K. Mesenchymal stem cell therapy in veterinary orthopaedics: Evidence from canine clinical medicine. Vet Res Commun 2025 Aug 28;49(5):290.
    doi: 10.1007/s11259-025-10843-4pubmed: 40875146google scholar: lookup
  3. Pimentel A, Gonçalves-Silva T, Jasmin, Mendez-Otero R. Isolation and characterization of canine umbilical cord mesenchymal/stromal stem cells. In Vitro Cell Dev Biol Anim 2025 Apr;61(4):472-485.
    doi: 10.1007/s11626-025-01023-4pubmed: 40325278google scholar: lookup
  4. Morawska-Kozłowska M, Pitas M, Zhalniarovich Y. Mesenchymal Stem Cells in Veterinary Medicine-Still Untapped Potential. Animals (Basel) 2025 Apr 19;15(8).
    doi: 10.3390/ani15081175pubmed: 40282009google scholar: lookup
  5. de Oliveira AT, Braga ARF, Miranda JRF, Fantinato-Neto P, Ambrósio CE. Mesenchymal stem cells in animal reproduction: sources, uses and scenario. Braz J Vet Med 2024;46:e002524.
    doi: 10.29374/2527-2179.bjvm002524pubmed: 38737577google scholar: lookup
  6. Abraham M, Kori I, Vishwakarma U, Goel S. Comprehensive assessment of goat adipose tissue-derived mesenchymal stem cells cultured in different media. Sci Rep 2024 Apr 10;14(1):8380.
    doi: 10.1038/s41598-024-58465-1pubmed: 38600175google scholar: lookup
  7. Quam VG, Belacic ZA, Long S, Rice HC, Dhar MS, Durgam S. Equine bone marrow MSC-derived extracellular vesicles mitigate the inflammatory effects of interleukin-1β on navicular tissues in vitro. Equine Vet J 2025 Jan;57(1):232-242.
    doi: 10.1111/evj.14090pubmed: 38587145google scholar: lookup
  8. Andreoli V, Berni P, Conti V, Ramoni R, Basini G, Grolli S. Mesenchymal Stromal Cells Derived from Canine Adipose Tissue: Evaluation of the Effect of Different Shipping Vehicles Used for Clinical Administration. Int J Mol Sci 2024 Mar 18;25(6).
    doi: 10.3390/ijms25063426pubmed: 38542399google scholar: lookup
  9. Ferreira-Baptista C, Ferreira R, Fernandes MH, Gomes PS, Colaço B. Influence of the Anatomical Site on Adipose Tissue-Derived Stromal Cells' Biological Profile and Osteogenic Potential in Companion Animals. Vet Sci 2023 Nov 24;10(12).
    doi: 10.3390/vetsci10120673pubmed: 38133224google scholar: lookup
  10. Caliani Carrera AL, Minto BW, Malard P, Brunel HDSS. The Role of Mesenchymal Stem Cell Secretome (Extracellular Microvesicles and Exosomes) in Animals' Musculoskeletal and Neurologic-Related Disorders. Vet Med Int 2023;2023:8819506.
    doi: 10.1155/2023/8819506pubmed: 38023428google scholar: lookup
  11. Burk J, Wittenberg-Voges L, Schubert S, Horstmeier C, Brehm W, Geburek F. Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses. Cells 2023 Oct 24;12(21).
    doi: 10.3390/cells12212513pubmed: 37947591google scholar: lookup
  12. Melzer M, Burk J, Guest DJ, Dudhia J. Influence of Rho/ROCK inhibitor Y-27632 on proliferation of equine mesenchymal stromal cells. Front Vet Sci 2023;10:1154987.
    doi: 10.3389/fvets.2023.1154987pubmed: 37346276google scholar: lookup
  13. Petrova V, Vachkova E. Outlook of Adipose-Derived Stem Cells: Challenges to Their Clinical Application in Horses. Vet Sci 2023 May 12;10(5).
    doi: 10.3390/vetsci10050348pubmed: 37235430google scholar: lookup
  14. Ismail HY, Hussein S, Shaker NA, Rizk H, Wally YR. Stem Cell Treatment Trials for Regeneration of Testicular Tissue in Laboratory Animals. Reprod Sci 2023 Jun;30(6):1770-1781.
    doi: 10.1007/s43032-022-01152-1pubmed: 36602652google scholar: lookup
  15. Hassan TA, Maher MA, El Karmoty AF, Ahmed ZSO, Ibrahim MA, Rizk H, Reyad AT. Auricular cartilage regeneration using different types of mesenchymal stem cells in rabbits. Biol Res 2022 Dec 26;55(1):40.
    doi: 10.1186/s40659-022-00408-zpubmed: 36572914google scholar: lookup
  16. El-Husseiny HM, Mady EA, Helal MAY, Tanaka R. The Pivotal Role of Stem Cells in Veterinary Regenerative Medicine and Tissue Engineering. Vet Sci 2022 Nov 21;9(11).
    doi: 10.3390/vetsci9110648pubmed: 36423096google scholar: lookup
  17. Trachsel DS, Stage HJ, Rausch S, Trappe S, Söllig K, Sponder G, Merle R, Aschenbach JR, Gehlen H. Comparison of Sources and Methods for the Isolation of Equine Adipose Tissue-Derived Stromal/Stem Cells and Preliminary Results on Their Reaction to Incubation with 5-Azacytidine. Animals (Basel) 2022 Aug 11;12(16).
    doi: 10.3390/ani12162049pubmed: 36009640google scholar: lookup
  18. Mizuno T, Inoue M, Kubo T, Iwaki Y, Kawamoto K, Itamoto K, Kambayashi S, Igase M, Baba K, Okuda M. Improvement of anemia in five dogs with nonregenerative anemia treated with allogeneic adipose-derived stem cells. Vet Anim Sci 2022 Sep;17:100264.
    doi: 10.1016/j.vas.2022.100264pubmed: 35898238google scholar: lookup
  19. Sharun K, Jambagi K, Kumar R, Gugjoo MB, Pawde AM, Tuli HS, Dhama K, Amarpal. Clinical applications of adipose-derived stromal vascular fraction in veterinary practice. Vet Q 2022 Dec;42(1):151-166.
    doi: 10.1080/01652176.2022.2102688pubmed: 35841195google scholar: lookup
  20. Rashid U, Yousaf A, Yaqoob M, Saba E, Moaeen-Ud-Din M, Waseem S, Becker SK, Sponder G, Aschenbach JR, Sandhu MA. Characterization and differentiation potential of mesenchymal stem cells isolated from multiple canine adipose tissue sources. BMC Vet Res 2021 Dec 18;17(1):388.
    doi: 10.1186/s12917-021-03100-8pubmed: 34922529google scholar: lookup